Actively Recruiting

Phase Not Applicable
Age: 22Years - 66Years
FEMALE
NCT05945329

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

Led by C. R. Bard · Updated on 2026-03-10

250

Participants Needed

32

Research Sites

216 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prospective, randomized, controlled study to assess the safety and effectiveness of GalaFLEX LITE™ Scaffold in revision surgery for reduction of capsular contracture recurrence and/or malposition in implant-based breast augmentation patients versus patients undergoing conventional revision surgery with no supportive matrix or acellular dermal matrix (ADM). Subjects will be randomized 2:1 to receive either GalaFLEX LITE™ Scaffold or standard care (no ADM or matrix placement). This study is designed using an adaptive approach. The number of the treated breasts will range between 250 and 530.

CONDITIONS

Official Title

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

Who Can Participate

Age: 22Years - 66Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Genetically female aged 22 to 66 years
  • Have Baker grade III or IV capsular contracture after breast augmentation
  • Desire a new implant with no more than a 25% increase in size and not exceeding 150cc volume increase
  • Plan revision surgery using an inframammary fold incision
  • Willing and able to follow study procedures including 2-year follow-up
  • Live within 3 hours driving distance from the study site
  • Provide signed and dated informed consent
Not Eligible

You will not qualify if you...

  • Body Mass Index (BMI) less than 18 or greater than 35
  • Existing or replacement implant size greater than 800 cc
  • Had two or more prior capsular contracture revisions on the treated breast(s)
  • Have extracapsular implant rupture in the breast(s) to be treated
  • Prior use of any synthetic or biologic matrix in the breast(s) to be treated
  • Abnormal diagnostic imaging within 1 year of enrollment (mammogram, MRI, or ultrasound as appropriate)
  • Symptoms consistent with Breast Implant Illness or Systemic Symptoms Associated with Breast Implants
  • Breast infection at time of surgery
  • Currently or recently (within 3 months) breastfeeding or history of mastitis within 6 months
  • Prior or current breast cancer diagnosis
  • Palpable breast mass not confirmed benign by imaging or biopsy
  • Prior chest radiation treatment
  • Chemotherapy within last 12 months
  • Current or recent (within 1 year) alcohol or substance abuse
  • Current or recent nicotine use within 4 weeks, including cigarettes, vaping, patches, gum
  • History of Breast Implant-Associated Anaplastic Large Cell Lymphoma or Breast Implant Associated Squamous Cell Carcinoma
  • Planned use of another matrix type in addition to GalaFLEX LITE22
  • Use of medical, physical, or device-assisted tools to manage breast capsules
  • Medical conditions posing high risk of complications (e.g., insulin-dependent diabetes, autoimmune diseases, connective tissue disorders, chronic lung or severe cardiovascular disease)
  • Planned or concurrent elective cosmetic breast surgery during study follow-up
  • Enrollment in another interfering clinical study
  • Pregnant or planning pregnancy during study period
  • Allergy to tetracycline hydrochloride or kanamycin sulfate
  • Any condition preventing study device use or outcome evaluation
  • Not remaining under investigator's care for all plastic surgery procedures during study
  • Active use of immunosuppressants such as oral steroids or biological therapies
  • Diagnosis of certain rheumatic or connective tissue diseases
  • Mental illness or disability precluding study participation
  • Breast implant was never commercially available in the USA
  • Implanted with any silicone implant other than breast implants
  • Taking drugs affecting blood clotting or increasing risk of complications
  • Employment or close relation to study sponsor, surgeon, or study staff

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 32 locations

1

Defyne MD

Scottsdale, Arizona, United States, 82521

Actively Recruiting

2

The Practice Plastic Surgery

Beverly Hills, California, United States, 90210

Actively Recruiting

3

California Aesthetic Center

Huntington Beach, California, United States, 92647

Actively Recruiting

4

Donald S Mowlds, MD A Professional Corporation

Newport Beach, California, United States, 92660

Actively Recruiting

5

Newport Plastic and Reconstructive Surgery Associates

Newport Beach, California, United States, 92660

Actively Recruiting

6

Stewart Wang MD Inc.

Pasadena, California, United States, 91101

Actively Recruiting

7

Charlie Chen MD., Corp

San Diego, California, United States, 92107

Actively Recruiting

8

Tim Sayed MD

San Diego, California, United States, 92121

Withdrawn

9

Beauty by Buford

Lone Tree, Colorado, United States, 80124

Actively Recruiting

10

Sanctuary Plastic Surgery

Boca Raton, Florida, United States, 33431

Withdrawn

11

Careaga Plastic Surgery

Miami, Florida, United States, 33134

Actively Recruiting

12

Aesthetic Enhancements Plastic Surgery

Orlando, Florida, United States, 32819

Actively Recruiting

13

Billington Plastic Surgery

St. Petersburg, Florida, United States, 33710

Actively Recruiting

14

VIVIFY Plastic Surgery

Tampa, Florida, United States, 33606

Actively Recruiting

15

The Graivier Center

Alpharetta, Georgia, United States, 30005

Actively Recruiting

16

Monarch Plastic Surgery and Skin Renewal Center

Atlanta, Georgia, United States, 30328

Actively Recruiting

17

Meridian Plastic Surgery Center

Indianapolis, Indiana, United States, 46290

Actively Recruiting

18

Reno Tahoe Plastic Surgery

Reno, Nevada, United States, 89511

Actively Recruiting

19

VIP Plastic Surgery

West Long Branch, New Jersey, United States, 07764

Actively Recruiting

20

Plastic Surgery Institute of New York

New York, New York, United States, 10036

Actively Recruiting

21

H/K/B Surgery

Huntersville, North Carolina, United States, 28078

Actively Recruiting

22

Essential Medical Research

Tulsa, Oklahoma, United States, 74137

Withdrawn

23

Pittsburgh Center for Plastic Surgery

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

24

The Plastic Surgery Center of Nashville With HKB

Nashville, Tennessee, United States, 37203

Actively Recruiting

25

Farah Naz Khan

Dallas, Texas, United States, 75219

Actively Recruiting

26

Southwest Plastic Surgery

El Paso, Texas, United States, 79936

Actively Recruiting

27

Aesthetic Center for Plastic Surgery

Houston, Texas, United States, 77024

Actively Recruiting

28

Hill Country Plastic Surgery

San Antonio, Texas, United States, 78257

Actively Recruiting

29

Next Stage Clinical Research

San Antonio, Texas, United States, 78258

Actively Recruiting

30

The Plastics Clinic

Draper, Utah, United States, 84020

Actively Recruiting

31

Athenix Advanced Plastic Surgery & Aesthetic Center

Seattle, Washington, United States, 98005

Actively Recruiting

32

Allen Gabriel MD

Vancouver, Washington, United States, 98660

Actively Recruiting

Loading map...

Research Team

N

Niccole Diaz

CONTACT

J

Jenna Baccari

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here